These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

743 related articles for article (PubMed ID: 18332176)

  • 1. Emergence of Serratia marcescens, Klebsiella pneumoniae, and Escherichia coli Isolates possessing the plasmid-mediated carbapenem-hydrolyzing beta-lactamase KPC-2 in intensive care units of a Chinese hospital.
    Cai JC; Zhou HW; Zhang R; Chen GX
    Antimicrob Agents Chemother; 2008 Jun; 52(6):2014-8. PubMed ID: 18332176
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Novel carbapenem-hydrolyzing beta-lactamase, KPC-1, from a carbapenem-resistant strain of Klebsiella pneumoniae.
    Yigit H; Queenan AM; Anderson GJ; Domenech-Sanchez A; Biddle JW; Steward CD; Alberti S; Bush K; Tenover FC
    Antimicrob Agents Chemother; 2001 Apr; 45(4):1151-61. PubMed ID: 11257029
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Underlying mechanisms of carbapenem resistance in extended-spectrum β-lactamase-producing Klebsiella pneumoniae and Escherichia coli isolates at a tertiary care centre in Lebanon: role of OXA-48 and NDM-1 carbapenemases.
    Baroud M; Dandache I; Araj GF; Wakim R; Kanj S; Kanafani Z; Khairallah M; Sabra A; Shehab M; Dbaibo G; Matar GM
    Int J Antimicrob Agents; 2013 Jan; 41(1):75-9. PubMed ID: 23142087
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Carbapenem-resistant strain of Klebsiella oxytoca harboring carbapenem-hydrolyzing beta-lactamase KPC-2.
    Yigit H; Queenan AM; Rasheed JK; Biddle JW; Domenech-Sanchez A; Alberti S; Bush K; Tenover FC
    Antimicrob Agents Chemother; 2003 Dec; 47(12):3881-9. PubMed ID: 14638498
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Phenotypic and molecular characteristics of carbapenem-non-susceptible Enterobacteriaceae from a teaching hospital in Wenzhou, southern China.
    Zhou T; Zhang X; Guo M; Ye J; Lu Y; Bao Q; Chi W
    Jpn J Infect Dis; 2013; 66(2):96-102. PubMed ID: 23514904
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Detection of a common plasmid carrying blaKPC-2 in Enterobacteriaceae isolates from distinct cities in China.
    Qi Y; Wei Z; Li L; Ji S; Du X; Shen P; Yu Y
    Microb Drug Resist; 2010 Dec; 16(4):297-301. PubMed ID: 20528100
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Molecular epidemiology of carbapenem resistant Enterobacteriaceae in Valle d'Aosta region, Italy, shows the emergence of KPC-2 producing Klebsiella pneumoniae clonal complex 101 (ST101 and ST1789).
    Del Franco M; Paone L; Novati R; Giacomazzi CG; Bagattini M; Galotto C; Montanera PG; Triassi M; Zarrilli R
    BMC Microbiol; 2015 Nov; 15(1):260. PubMed ID: 26552763
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Emergence of Serratia marcescens isolates possessing carbapenem-hydrolysing β-lactamase KPC-2 from China.
    Lin X; Hu Q; Zhang R; Hu Y; Xu X; Lv H
    J Hosp Infect; 2016 Sep; 94(1):65-7. PubMed ID: 27160868
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Detection of plasmid-mediated carbapenem-hydrolyzing beta-lactamase KPC-2 in a strain of carbapenem-resistant Enterobacter cloacae].
    Cai JC; Zhou HW; Chen GX; Zhang R
    Zhonghua Yi Xue Za Zhi; 2008 Jan; 88(2):135-8. PubMed ID: 18353225
    [TBL] [Abstract][Full Text] [Related]  

  • 10. "Silent" dissemination of Klebsiella pneumoniae isolates bearing K. pneumoniae carbapenemase in a long-term care facility for children and young adults in Northeast Ohio.
    Viau RA; Hujer AM; Marshall SH; Perez F; Hujer KM; Briceño DF; Dul M; Jacobs MR; Grossberg R; Toltzis P; Bonomo RA
    Clin Infect Dis; 2012 May; 54(9):1314-21. PubMed ID: 22492318
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prevalence of plasmid-mediated AmpC beta-lactamases in a Chinese university hospital from 2003 to 2005: first report of CMY-2-Type AmpC beta-lactamase resistance in China.
    Li Y; Li Q; Du Y; Jiang X; Tang J; Wang J; Li G; Jiang Y
    J Clin Microbiol; 2008 Apr; 46(4):1317-21. PubMed ID: 18305137
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Combination of IMP-4 metallo-beta-lactamase production and porin deficiency causes carbapenem resistance in a Klebsiella oxytoca clinical isolate.
    Chen LR; Zhou HW; Cai JC; Zhang R; Chen GX
    Diagn Microbiol Infect Dis; 2009 Oct; 65(2):163-7. PubMed ID: 19748427
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Carbapenem resistance due to Bla(OXA-48) among ESBL-producing Escherichia coli and Klebsiella pneumoniae isolates in a univesity hospital, Turkey.
    Nazik H; Ongen B; Ilktac M; Aydin S; Kuvat N; Sahin A; Yemisen M; Mete B; Durmus MS; Balkan II; Yildiz I; Ergul Y
    Southeast Asian J Trop Med Public Health; 2012 Sep; 43(5):1178-85. PubMed ID: 23431824
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Emergence of Escherichia coli sequence type 410 (ST410) with KPC-2 β-lactamase.
    Mavroidi A; Miriagou V; Malli E; Stefos A; Dalekos GN; Tzouvelekis LS; Petinaki E
    Int J Antimicrob Agents; 2012 Mar; 39(3):247-50. PubMed ID: 22226650
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The mechanism of high-level carbapenem resistance in Klebsiella pneumoniae: underlying Ompk36-deficient strains represent a threat of emerging high-level carbapenem-resistant K. pneumoniae with IMP-1 β-lactamase production in Japan.
    Sho T; Muratani T; Hamasuna R; Yakushiji H; Fujimoto N; Matsumoto T
    Microb Drug Resist; 2013 Aug; 19(4):274-81. PubMed ID: 23514607
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Phenotypic and genotypic screening and clonal analysis of carbapenem-resistant Klebsiella pneumoniae at a single hospital.
    Gomez E; Urban C; Mariano N; Colon-Urban R; Eng RH; Huang DB; Chiang T
    Microb Drug Resist; 2011 Jun; 17(2):251-7. PubMed ID: 21332362
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Genomic characterization of two carbapenem-resistant
    Jia J; Huang L; Zhang L; Sheng Y; Chu W; Xu H; Xu A
    Front Cell Infect Microbiol; 2023; 13():1075255. PubMed ID: 36844412
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Reduced susceptibility to carbapenems in Klebsiella pneumoniae clinical isolates associated with plasmid-mediated beta-lactamase production and OmpK36 porin deficiency.
    Wang XD; Cai JC; Zhou HW; Zhang R; Chen GX
    J Med Microbiol; 2009 Sep; 58(Pt 9):1196-1202. PubMed ID: 19528170
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Carbapenem and cefoxitin resistance of Klebsiella pneumoniae strains associated with porin OmpK36 loss and DHA-1 β-lactamase production.
    Shi W; Li K; Ji Y; Jiang Q; Wang Y; Shi M; Mi Z
    Braz J Microbiol; 2013; 44(2):435-42. PubMed ID: 24294234
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Characterization of a large outbreak by CTX-M-1-producing Klebsiella pneumoniae and mechanisms leading to in vivo carbapenem resistance development.
    Mena A; Plasencia V; García L; Hidalgo O; Ayestarán JI; Alberti S; Borrell N; Pérez JL; Oliver A
    J Clin Microbiol; 2006 Aug; 44(8):2831-7. PubMed ID: 16891499
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 38.